Product image of Medrol A (Methylprednisolone) supplied by GNH India

Medrol A

Active Ingredient:
Methylprednisolone
Origin:
EU

Medrol A (Methylprednisolone)

Methylprednisolone, the active ingredient in Medrol A, is a corticosteroid presented as an oral formulation for oral use. It treats inflammatory and immune‑mediated conditions in adults and children as prescribed.

GNH India supplies Medrol A as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Pfizer Europe Ma Eeig

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Methylprednisolone is used to manage inflammatory and immune‑mediated disease pathways.
  • Inflammatory disorders: reduces swelling, pain and tissue damage in conditions such as rheumatoid arthritis.
  • Allergic reactions: diminishes severe hypersensitivity symptoms and airway edema.
  • Autoimmune diseases: suppresses aberrant immune activity in disorders like systemic lupus erythematosus.
  • Asthma: improves airflow by decreasing airway inflammation.
  • Rheumatoid arthritis: limits joint destruction and improves functional capacity.

How It Works

  • Methylprednisolone binds to intracellular glucocorticoid receptors, forming a complex that translocates to the nucleus and modulates gene transcription. This interaction up‑regulates anti‑inflammatory proteins and down‑regulates pro‑inflammatory cytokines, leading to reduced immune cell activation, decreased vascular permeability, and overall suppression of inflammatory pathways.

Side Effects

Methylprednisolone may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Increased appetite and weight gain.
  • Insomnia or difficulty sleeping.
  • Mood swings, including irritability or euphoria.
  • Mild hyperglycemia.
  • Stomach irritation or dyspepsia.
  • Fluid retention causing mild edema.

Serious or Rare Side Effects

  • Adrenal insufficiency on abrupt discontinuation.
  • Severe infections due to immunosuppression.
  • Osteoporosis and increased fracture risk.
  • Psychosis or severe mood disorders.
  • Marked hyperglycemia or diabetic ketoacidosis.
  • Anaphylactic reactions.

Precautions & Warnings

  • Before initiating therapy, clinicians should evaluate patient‑specific risk factors and monitor for complications.
  • Assess infection risk: screen for active infections and avoid use in uncontrolled sepsis.
  • Monitor blood glucose: check glucose levels regularly, especially in diabetic patients.
  • Evaluate bone health: consider calcium/vitamin D supplementation and bone density monitoring.
  • Taper therapy: gradually reduce dose to prevent adrenal crisis.
  • Avoid abrupt discontinuation: ensure proper tapering schedule.
  • Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Methylprednisolone can interact with several drug classes, requiring careful management.

Major Interactions (Avoid)

  • Strong CYP3A4 inhibitors (e.g., ketoconazole): may increase steroid levels.
  • Live vaccines: risk of severe infection due to immunosuppression.
  • Anticoagulants (warfarin): enhanced anticoagulant effect, increased bleeding risk.
  • NSAIDs: heightened gastrointestinal ulceration and bleeding.
  • Diuretics (loop or thiazide): may exacerbate potassium loss.

Moderate Interactions (Monitor Closely)

  • CYP3A4 inducers (e.g., rifampin): may reduce steroid efficacy.
  • Antidiabetic agents: possible need for dose adjustment due to altered glucose control.
  • ACE inhibitors or ARBs: potential for enhanced potassium retention.
  • Antifungal agents (moderate inhibitors): may modestly raise steroid concentrations.

Frequently Asked Questions

Medrol A contains methylprednisolone, a glucocorticoid that is prescribed for inflammatory disorders, severe allergic reactions, autoimmune diseases, asthma, and rheumatoid arthritis. It works by reducing inflammation and modulating the immune response in these conditions.

Methylprednisolone binds to intracellular glucocorticoid receptors, altering gene transcription. This leads to increased production of anti‑inflammatory proteins and suppression of pro‑inflammatory cytokines, thereby decreasing immune cell activity and reducing swelling, pain, and tissue damage.

The dosage of Medrol A is individualized by the prescribing clinician based on the specific condition, severity, patient age, weight, and response to therapy. Only a qualified health professional should determine the appropriate dose and schedule.

The safety of methylprednisolone in pregnancy and lactation has not been definitively established. It should be used only if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by the treating physician.

To order Medrol A, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Methylprednisolone offers a potency intermediate between prednisone and dexamethasone, providing strong anti‑inflammatory effects with a relatively favorable side‑effect profile. Choice of corticosteroid depends on the clinical scenario, required potency, duration of action and physician preference.

Medrol A should be stored at ambient temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Medrol A is taken orally, usually with food or a full glass of water to reduce gastrointestinal irritation. The exact administration schedule—once daily, divided doses, or tapering—must follow the prescribing clinician’s instructions.

Serious risks include adrenal suppression, severe infections, osteoporosis, significant hyperglycemia, and rare psychiatric effects such as psychosis. Patients should be monitored closely for signs of infection, bone loss, blood‑sugar changes, and mood alterations.

Medrol A is contraindicated in patients with known hypersensitivity to methylprednisolone or any component of the formulation, and it should be avoided in individuals with uncontrolled systemic infections, active peptic ulcer disease, or severe uncontrolled diabetes without appropriate medical supervision.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Methylprednisolone

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT